Trading Statement

Victrex PLC 04 October 2007 Thursday 4 October 2007 Victrex plc Annual Trading Update and Completion of second VICTREX(R) PEEK(TM) polymer plant Annual Trading Update The Company announces its trading update for the year ended 30 September 2007. We expect profits for the year to be in line with analysts' expectations with record annual sales volume and better than expected second half margins. Sales volume for the year grew by 7% to approximately 2,508 tonnes (2006: 2,339 tonnes). Second half sales volume of around 1,222 tonnes was in line with the previous second half (1,226 tonnes) but 5% down on the first half (1,286 tonnes) . However, group sales volume in August and September increased to levels similar to those achieved in the first half. •United States full year sales volume of 791 tonnes was 9% up on the previous year (724 tonnes). Second half sales volume of 402 tonnes was up 3% from 389 tonnes in the first half. •Asia-Pacific sales volume of 474 tonnes for the year was up 13% on 2006 (419 tonnes). Second half sales volume of 233 tonnes was in line with the record first half performance of 241 tonnes. •At 1,243 tonnes, European sales volume was 4% up on the previous year (1,196 tonnes) although second half sales volume of 587 tonnes was 11% down on the strong first half of this year (656 tonnes). This was largely due to reduced electronics sales, principally to European processors for use in Asia-Pacific applications. •Full year revenue of Invibio(R), our biomaterial business, grew by 25% to approximately £19.2m, compared with last year (£15.4m). As expected, second half revenue was in line with the first half of £9.5m. Looking ahead, we continue to see opportunities to increase our sales volume and remain confident in the fundamentals underlying the business. Consequently, we look forward to further progress being made. The announcement of the Company's results for the year ended 30 September 2007 will be made on Tuesday, 11 December 2007. Completion of second VICTREX(R) PEEK(TM) polymer plant Victrex also announces the completion of construction of its second VICTREX PEEK polymer powder plant at a capital cost of approximately £32m, which will be depreciated over its estimated useful life of 30 years. The plant has the capacity to support a further 1,450 tonnes per annum of VICTREX PEEK sales and is expected to be fully operational by the end of the year. As previously reported, we have also commenced the uprate of the BDF supply chain (our key raw material) to support this additional polymer capacity at an estimated capital cost of £23m with completion expected in autumn 2008. -Ends- For further information please contact: Victrex plc 01253 897700 Michael Peacock, Finance Director Hogarth Partnership Limited 0207 357 9477 Nick Denton / Barnaby Fry Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX(R) PEEK(TM) polymer, a high performance, easy to process thermoplastic. VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis and temperature resistance, as well as excellent dimensional, mechanical and chemical stability combined with inherent purity and low flammability. End users specify VICTREX PEEK to reduce systems costs, improve part performance, exploit greater design freedom and create a differentiated application. VICTREX PEEK is used across a broad range of applications in diverse markets including transport, industrial, electronics and medical. Invibio(R), Victrex's biomaterial business, provides specialised solutions for medical device manufacturers. The Group's headquarters are in the UK where its manufacturing facilities are based. This is complemented by a global network of sales, distribution and technical centres that serve more than 30 countries worldwide. This information is provided by RNS The company news service from the London Stock Exchange

Companies

Victrex plc (VCT)
UK 100

Latest directors dealings